Patient No. | Posttreatment Ischemic Lesions (CT) | mRS at Discharge* | mRS at 3-Month Follow-Up* | Adverse Effects |
---|---|---|---|---|
1 | Minor | 5 | 4 | None |
2 | Minor | 5 | 4 | Hypotension |
3 | Minor | 5 | 2 | Hypotension |
4 | Minor | 6 | – | None |
5 | No | 0 | 0 | None |
6 | No | 2 | 1 | None |
7 | Minor | 4 | – | Hypotension |
8 | No | 0 | 0 | Hypotension |
9 | No | 2 | 1 | None |
10 | Minor | 1 | 1 | None |
11 | Minor | 0 | 0 | None |
12 | No | 0 | 0 | None |
13 | No | 0 | 0 | Hypotension |
14 | No | 0 | 0 | None |
15 | Major | 6 | – | Hypotension |
16 | Minor | 1 | – | None |
17 | Minor | 0 | 0 | None |
18 | Minor | 5 | 5 | None |
Note:—mRS, indicates modified Rankin Scale.
* Scores of 0–2 indicate good outcome; 3–4, moderate outcome; 5–6, poor outcome.